Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option
Description
INTRODUCTION: The COVID-19 pandemic stimulated the development of several therapeutic tools with several degrees of success. Ensitrelvir, a protease inhibitor that blocks the replication of SARS-CoV-2, can reduce the viral load and the severity of
